NASDAQ:GTXI GTX (GTXI) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free GTXI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$8.53▼$9.0050-Day Range$1.20▼$7.2052-Week Range$0.74▼$25.60Volume955 shsAverage Volume390,540 shsMarket Capitalization$210.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get GTX alerts: Email Address Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… About GTX Stock (NASDAQ:GTXI)GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for the treatment of stress urinary incontinence (SUI) and prostate cancer. It develops selective androgen receptor modulators (SARMs) for the treatment of breast cancer, SUI, and Duchenne muscular dystrophy; and selective androgen receptor degraders to treat progressive castration-resistant prostate cancer. The company's SARM product candidate is the enobosarm GTx-024, a Phase II proof-of-concept clinical trial for patients with androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.Read More Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… GTXI Stock News HeadlinesApril 22, 2024 | msn.comThe Witcher 3: Wild Hunt Mods Now Available on SteamApril 22, 2024 | msn.com5 Of The Best Affordable Graphics Cards You Can Get In 2024April 23, 2024 | Stansberry Research (Ad)The "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. April 22, 2024 | msn.comOriginal Joe Dirt Dodge Charger Daytona Movie Car Sells for $330,000April 18, 2024 | markets.businessinsider.comBuy Rating on Ultragenyx Pharmaceutical Bolstered by GTX-102’s Promise and Positive Valuation OutlookApril 17, 2024 | msn.comExclusive: Former ministry official leads GTX-A rail project with hefty compensationApril 17, 2024 | msn.comSony’s new PlayStation PC overlay and shared Trophies arrive with Ghost of TsushimaApril 17, 2024 | bizjournals.comUS Farathane, a supplier to Tesla and other automakers, sees Austin metro as a key part of its growthApril 23, 2024 | Stansberry Research (Ad)The "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. April 14, 2024 | msn.comRestoring a Classic: 1970 Plymouth Road Runner Barn FindApril 10, 2024 | markets.businessinsider.comBuy Rating for Garrett Motion Backed by Strategic Shift Towards Zero Emission and Hybrid Market GrowthApril 4, 2024 | msn.comHow Do You Like Your Mopar B-body Muscle: Coronet R/T Convertible or GTX Hardtop Coupe?March 25, 2024 | msn.comPlymouth GTX: A Classic Muscle Car’s Rise in Collector’s ValueMarch 21, 2024 | msn.comVolkswagen reveals hot new ID Buzz GTXMarch 21, 2024 | msn.comThe Volkswagen ID. Buzz GTX Is a Spicy Electric Van With 335 HPMarch 21, 2024 | msn.comVolkswagen ID. Buzz GTX Is A Hot Electric Minivan With 335 HP And All-Wheel DriveMarch 19, 2024 | msn.comVolkswagen Unveils ID.3 and Tourer GTX in Electrifying New VideoMarch 18, 2024 | msn.comVolkswagen Unveils New ID.3 and Tourer GTX EVs in Official VideoMarch 15, 2024 | msn.comThe design and equipment of the Volkswagen ID.3 GTXMarch 14, 2024 | msn.comVW ID.7 GTX Tourer: High-Performance Electric Wagon PreviewMarch 14, 2024 | msn.comNew GTX Performance Models Elevate Volkswagen’s ID.3 and ID.7 Tourer Electric VehiclesMarch 14, 2024 | msn.comVW Reveals ID.3 GTX And ID.7 GTX Tourer: High-Performance EVs For EuropeMarch 14, 2024 | msn.comVolkswagen Introduces ID.7 GTX Tourer, Boasting Greater Power Than Golf RMarch 14, 2024 | msn.comVolkswagen ID.3 GTX debuts as brand’s first electric hot hatchMarch 13, 2024 | msn.comIs the VW ID.3 GTX the electric hot hatch you’ve been waiting for?March 13, 2024 | msn.comThe 322-HP ID.3 GTX Is Volkswagen's First Electric Hot HatchMarch 13, 2024 | msn.comVW Reveals 322-HP ID.3 GTX EV Hot Hatch and 335-HP ID.7 GTX WagonSee More Headlines Receive GTXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2018Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:GTXI CUSIP40052B10 CIK1260990 Webwww.gtxinc.com Phone901-523-9700FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-38,420,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-104.19% Return on Assets-86.42% Debt Debt-to-Equity RatioN/A Current Ratio12.39 Quick Ratio12.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book7.84Miscellaneous Outstanding Shares24,050,000Free FloatN/AMarket Cap$205.63 million OptionableNot Optionable Beta2.22 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesDr. Robert James Wills B.S. (Age 65)M.S., Ph.D., Exec. Chairman Mr. Marc S. Hanover (Age 56)Co-Founder, CEO & Director Mr. Henry P. Doggrell (Age 70)VP, Chief Legal Officer & Sec. Mr. Jason T. Shackelford (Age 44)VP of Fin. & Accounting, Principal Financial & Accounting Officer and Corp. Controller Dr. Diane C. Young (Age 62)VP & Chief Medical Officer Key CompetitorsRigel PharmaceuticalsNASDAQ:RIGLVanda PharmaceuticalsNASDAQ:VNDARegulus TherapeuticsNASDAQ:RGLSVerastemNASDAQ:VSTMXOMANASDAQ:XOMAView All Competitors GTXI Stock Analysis - Frequently Asked Questions How were GTX's earnings last quarter? GTx, Inc. (NASDAQ:GTXI) released its quarterly earnings data on Thursday, November, 15th. The biopharmaceutical company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.09. What other stocks do shareholders of GTX own? Based on aggregate information from My MarketBeat watchlists, some companies that other GTX investors own include Corbus Pharmaceuticals (CRBP), Synergy Pharmaceuticals (SGYP), Novavax (NVAX), Inovio Pharmaceuticals (INO), Verastem (VSTM), Catalyst Pharmaceuticals (CPRX), MEI Pharma (MEIP), Progenics Pharmaceuticals (PGNX), Rigel Pharmaceuticals (RIGL) and Amarin (AMRN). This page (NASDAQ:GTXI) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GTx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
